Skip to content

COVID-19 and Pregnancy Outcomes

COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04416373
Acronym
COVID&PREG
Enrollment
300
Registered
2020-06-04
Start date
2020-03-22
Completion date
2023-12-31
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Coronavirus Infection, Neonatal Infection, Pregnancy Complications, Vertical Transmission of Infectious Disease

Brief summary

This is a multicenter prospective study that aims to investigate the clinical impact of SARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.

Detailed description

This is a cohort study of pregnant women confirmed positive for SARS-CoV-2 infection. Data will be collected in Portuguese maternities that agreed to collaborate in this study. Pregnant women are tested during hospital admission by using nasopharyngeal/oral swabs for SARS-CoV-2 RT PCR as part of a universal testing policy. Maternal demographic data (age, comorbidities, parity, smoking habits), COVID-19 related data (symptoms, diagnostic tests, therapy used and ICU admission), gestational age at SARS-CoV-2 confirmed infection, pregnancy outcomes (gestational complications, gestational age at birth, mode of delivery) and neonatal outcome (birthweight and Apgar score, RT PCR neonate results) and breastfeeding strategies will be evaluated.

Interventions

DIAGNOSTIC_TESTRT PCR SARS-CoV-2

Positive SARS-CoV-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood samples

Sponsors

Universidade Nova de Lisboa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

Pregnant women infected with Sars-Cov-2. Delivery at Portuguese maternities.

Exclusion criteria

RT PCR SARS-CoV-2 negative. \-

Design outcomes

Primary

MeasureTime frameDescription
SARS-CoV-2 Neonatal Infection7 daysPositive Sars-Cov-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood samples

Secondary

MeasureTime frameDescription
ICU maternal admission35 weeksmaternal ICU admission due to COVID-19
5 minute Apgar Score < 71 dayNewborn 5 minute Apgar Score \< 7
Perinatal mortality35 weeksstillbirths and deaths in the first week of life
PPROM35 weeksPreterm premature rupture of the membranes between 24 and 36 weeks
Miscarriage14 weeksspontaneous pregnancy loss before 24 weeks
Preterm labour35 weeksDelivery between 24 and 36 weeks

Countries

Portugal

Contacts

Primary ContactNadia Charepe, MD,MSc
nadia.charepe@chlc.min-saude.pt00351213184000
Backup ContactAlexandra Queirós, MD
alexandra.queiros@nms.unl.pt00351213184000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026